COSCIENS Biopharma Inc. Restricted Cash And Cash Equivalents
COSCIENS Biopharma Inc. (CSCIF) had Restricted Cash And Cash Equivalents of $125.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2026-03-25
- 2025-12-31: Restricted Cash And Cash Equivalents $125.00K.
- 2025-09-30: Restricted Cash And Cash Equivalents $132.00K.
- 2025-06-30: Restricted Cash And Cash Equivalents $132.00K.
- 2025-03-31: Restricted Cash And Cash Equivalents $128.00K.
| Period end | Restricted Cash And Cash Equivalents | Restricted Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $125.00K 20-F · filed 2026-03-25 | |
| 2025-09-30 | $132.00K 6-K · filed 2025-11-12 | |
| 2025-06-30 | $132.00K 6-K · filed 2025-08-14 | |
| 2025-03-31 | $128.00K 6-K · filed 2025-05-13 | |
| 2024-12-31 | $123.00K 20-F · filed 2026-03-25 | |
| 2024-09-30 | $126.00K 6-K · filed 2024-11-12 | |
| 2024-06-30 | $332.00K 6-K · filed 2024-08-13 | |
| 2024-03-31 | $326.00K 6-K · filed 2024-05-16 | |
| 2023-12-31 | $8.00K 20-F · filed 2025-04-09 | $332.00K 20-F · filed 2024-03-27 |
| 2023-09-30 | $320.00K 6-K · filed 2023-11-09 | |
| 2023-06-30 | $325.00K 6-K · filed 2023-08-09 | |
| 2023-03-31 | $326.00K 6-K · filed 2023-05-09 | |
| 2022-12-31 | $322.00K 20-F/A · filed 2024-07-17 | |
| 2022-09-30 | $300.00K 6-K · filed 2022-11-03 | |
| 2022-06-30 | $314.00K 6-K/A · filed 2022-08-04 | |
| 2022-03-31 | $330.00K 6-K · filed 2022-05-11 | |
| 2021-12-31 | $335.00K 20-F/A · filed 2024-02-15 | |
| 2021-09-30 | $342.00K 6-K · filed 2021-11-04 | |
| 2021-06-30 | $328.00K 6-K · filed 2021-08-05 | |
| 2021-03-31 | $325.00K 6-K · filed 2021-05-05 | |
| 2020-12-31 | $338.00K 20-F · filed 2022-03-29 | |
| 2020-09-30 | $325.00K 6-K · filed 2020-11-05 | |
| 2020-06-30 | $313.00K 6-K · filed 2020-08-06 | |
| 2020-03-31 | $358.00K 6-K/A · filed 2020-05-11 | |
| 2019-12-31 | $364.00K 40-F/A · filed 2021-03-29 | |
| 2019-09-30 | $356.00K 6-K · filed 2019-11-07 | |
| 2019-06-30 | $367.00K 6-K · filed 2019-08-13 | |
| 2018-12-31 | $418.00K 20-F · filed 2020-03-31 | |
| 2017-12-31 | $381.00K 20-F · filed 2019-04-01 | |
| 2016-12-31 | $496.00K 20-F · filed 2018-03-28 |